HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth I Minder Selected Research

Ferrochelatase (Heme Synthetase)

1/2020Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria.
11/2019Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
1/2017Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
1/2017Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
10/2013Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
12/2010Exacerbation of erythropoietic protoporphyria by hyperthyroidism.
4/2007Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.
5/2003A "null allele" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth I Minder Research Topics

Disease

16Erythropoietic Protoporphyria
01/2021 - 05/2003
7Phototoxic Dermatitis (Phototoxicity)
11/2019 - 03/2009
7Acute Intermittent Porphyria (Porphyria, Acute)
03/2015 - 01/2002
4Iron Deficiencies
11/2019 - 10/2013
3Hypochromic Anemia (Chlorosis)
11/2019 - 01/2015
2Pain (Aches)
01/2017 - 11/2009
2Anemia
01/2017 - 01/2017
2Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
07/2015 - 02/2010
2Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency)
03/2015 - 08/2006
2Porphyrias (Porphyria)
04/2009 - 08/2006
1Acute Erythroblastic Leukemia (Erythroleukemia)
01/2021
1Liver Diseases (Liver Disease)
01/2017
1Inflammation (Inflammations)
01/2017
1Chronic Disease (Chronic Diseases)
01/2017
1Liver Neoplasms (Liver Cancer)
03/2015
1Melanoma (Melanoma, Malignant)
03/2013
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2012
1Skin Diseases (Skin Disease)
12/2010
1Graves Disease (Basedow Disease)
12/2010
1Rare Diseases (Rare Disease)
12/2010
1Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
08/2010
1Erythema
11/2009
1Edema (Dropsy)
11/2009
1Endometrial Neoplasms (Endometrial Cancer)
03/2009
1Pulmonary Embolism
06/2003
1Acute Coronary Syndrome
06/2003
1Sepsis (Septicemia)
06/2003
1Stroke (Strokes)
06/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2003
1Critical Illness (Critically Ill)
06/2003
1Renal Insufficiency (Renal Failure)
06/2003

Drug/Important Bio-Agent (IBA)

10Heme (Haem)IBA
11/2019 - 03/2002
8protoporphyrin IXIBA
01/2021 - 03/2009
8Ferrochelatase (Heme Synthetase)IBA
01/2020 - 05/2003
6Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
03/2015 - 01/2002
5EnzymesIBA
11/2019 - 12/2010
5IronIBA
11/2019 - 01/2015
5afamelanotideIBA
01/2017 - 12/2010
3Melanocyte-Stimulating Hormones (MSH)IBA
01/2015 - 12/2010
2Protoporphyrinogen Oxidase (Protox)IBA
03/2015 - 08/2006
2AcidsIBA
01/2015 - 03/2009
2AntibodiesIBA
01/2015 - 12/2010
2Pharmaceutical PreparationsIBA
12/2010 - 04/2009
2alpha-MSHIBA
11/2009 - 01/2009
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2021
1OligonucleotidesIBA
01/2020
1Ferritins (Ferritin)IBA
11/2019
1Aminolevulinic Acid (Levulan)FDA Link
11/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Type 1 Melanocortin ReceptorIBA
01/2017
1Melanins (Melanin)IBA
01/2017
1AntioxidantsIBA
01/2017
1IsoenzymesIBA
01/2015
1Proteins (Proteins, Gene)FDA Link
10/2013
1Small Interfering RNA (siRNA)IBA
10/2013
1DioxygenasesIBA
10/2013
1Splicing Factor U2AFIBA
10/2013
1Neutralizing AntibodiesIBA
03/2013
1heme arginateIBA
01/2012
1Charcoal (Charbon)IBA
01/2012
1Glucose (Dextrose)FDA LinkGeneric
01/2012
1AlbuminsIBA
01/2012
1Iodide Peroxidase (Deiodinase)IBA
12/2010
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2010
1Thyroxine (Levothyroxine)FDA LinkGeneric
12/2010
1Triiodothyronine (Liothyronine)FDA LinkGeneric
12/2010
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
12/2010
1Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
02/2010
1Photosensitizing Agents (Photosensitizers)IBA
11/2009
1hypericinIBA
03/2009
1TroponinIBA
06/2003

Therapy/Procedure

2Liver Transplantation
01/2012 - 05/2003
1Hemodiafiltration
01/2012
1Therapeutics
12/2010